Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

Carcinogenesis

Volumn 20, Issue 10, 1999, Pages 1905-1911

  Clay, Carl E ^a   Namen, Andrew M ^a   Atsumi, Gen Ichi ^a   Willingham, Mark C ^a   High, Kevin P ^a   Kute, Timothy E ^a   Trimboli, Anthony J ^a   Fonteh, Alfred N ^a   Dawson, Paul A ^a   Chilton, Floyd H ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY 12,14 PROSTAGLANDIN J2; ESTROGEN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN DERIVATIVE; PROSTANOID; TROGLITAZONE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CELL COUNT; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOLYSIS; DOSE RESPONSE; HUMAN; HUMAN CELL; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DIFFERENTIATION;

EID: 0032884254     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.10.1905     Document Type: Article

References (45)

1. Heyman, R.A., Mangelsdorf, D.J., Dyck, J.A., Stein, R.B., Eichele, G., Evans, R.M. and Thaller, C. (1992) 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 68, 397-406.
2. Levin, A.A., Sturzenburger, U., Kazmer, S. et al. (1992) 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature, 23, 359-361.
3. Moon, R.C. Mehta, R.G. and Rao, K.V.N. (1994) Retinoids and cancer in experimental animals. In Sporn, M.B., Roberts, A.B. and Goodman, D.S. (eds) The Retinoids: Biology, Chemistry and Medicine, 2nd Edn. Raven Press, New York, NY, pp. 573-595.
4. Marth, R.C., Mayer, I. and Daxenbichler, G. (1984) Effect of retinoic acid and 4-hydroxytamoxifen on human breast cancer cell lines. Biochem. Pharmacol., 33, 2217-2221.
5. Fontana, J.A., Miranda, D. and Mezu, A.B. (1990) Retinoic acid inhibition of human breast carcinoma proliferation is accompanied by inhibition of the synthesis of a Mr 39,000 protein. Cancer Res., 50, 1977-1982.
6. van der Burg, B., van der Leede, B.M., Kwakkenbos-Isbrucker, L., Salverda, S., de Lat, S.W. and van der Saag, P.T. (1993) Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol., 91, 149-157.
7. Dawson, M.I., Chao, W., Pine, P. et al. (1995) Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Cancer Res., 55, 4446-4451.
8. Elstner, E., Linker-Israeli, M., Umiel, T. et al. (1997) Combination of a potent 20-epi-vitamin D3 analogue (KH1060) with 9-cis -retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res., 56, 3570-3576.
9. Elstner, E., Linker-Israeli, M., Le, J., Umiel, T., Michl, P., Said, J.W., Binderup, L., Reed, J.C. and Koeffler, H.P. (1997) Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid. J. Clin. Invest., 99, 349-360.
10. Toma, S., Isnard, L., Raffo, P., Dastoli, G., DeFrancisi, E., Riccardi, L., Palumbo, R. and Bollag, W. (1996) Effects of all-trans-retinoic acid and 13-cis-retinoic acid on breast cancer cell lines: growth inhibition and apoptosis induction. Int. J. Cancer, 70, 619-627.
11. Chwala, A., Schwartz, E.J., Dimaculangan, D.D. and Lazar, M.A. (1994) Peroxisome proliferator-activated receptor (PPAR) gamma: adipose predominant expression and induction early in adipocyte differentiation. Endocrinology, 135, 798-800.
12. Tontonoz, P., Hu, E., Graves, R.A., Budavari, A.I., and Spiegelman, B.M. (1994) mPPAR gamma2: tissue specific regulator of an adipocyte enhancer. Genes Der., 8, 1224-1234.
13. Tontonoz, P., Hu, E. and Spiegleman, B.M. (1994) Stimulation of adipogenesis in fibroblasts by PPARγ2, a ligand-activated transcription factor. Cell, 79, 1147-1156.
14. Lambe, K.G. and Tugwood, J.D. (1996) A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur. J. Biochem., 239, 1-7.
15. Tontonoz, P., Singer, S., Forman, B.M. et al. (1997) Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc. Natl Acad. Sci. USA, 94, 237-241.
16. Hu, E., Tontonoz, P. and Spiegelman, B.M. (1995) Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/ EBP alpha. Proc. Natl Acad. Sci. USA, 92, 9856-9860.
17. Lehman, J.M., Moore, L.B., Smith-Oliver, T.A., Wilison, W.O., Willson, T.M. and Kliewer, S.A. (1995) An antidiabetic thiazolidinedione is a high afinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem., 270, 12953-12956.
18. Kliewer, S.A., Sundseth, S.S., Jones, S.A. et al. (1997) Fatty acids and eicosanoids regulate gene expression through direct interaction with peroxisome proliferator-activated receptors α and γ. Proc. Natl Acad. Sci. USA, 94, 4318-4323.
19. Yu, K., Bayona, W., Kallen, C.B., Harding, H.P., Ravera, C.P., McMahon, G., Brown, M. and Lazar, M.A. (1995) Differential activation of peroxisome proliferator activated receptors by eicosanoids. J. Biol. Chem., 270, 23975-23983.
20. Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegleman, B.M. and Evans, R.M. (1995) 15-deoxy-Δ12,14 prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ Cell, 83, 803-812.
21. Kliewer, S.A., Lenhard, J.M., Wilson, J.M., Patel, I., Morris, D.C. and Lehmann, J.M. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell, 83, 813-819.
22. Kliewer, S.A., Umesono, K., Noonan, D.J., Heyman, R.A. and Evans, R.M. (1992) Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature, 358, 771-774.
23. Kilgore, M.W., Tate, P.L., Rai, S., Sengoku, E. and Price, T.M. (1997) MCF-7 and T47D human breast cancer cells contain a functional peroxisomal response. Mol. Cell. Endocrinol., 129, 229-235.
24. Mueller, E., Sarraf, P., Tontonoz, P., Evans, R.M., Martin, K.J., Zhang, M., Fletcher, C. and Spiegelman, B.M. (1998) Terminal differentiation of human breast cancer through PPARγ. Mol. Cell, 1, 465-470.
25. DuBois, R.N., Gupta, R., Brockman, J., Reddy, B.S., Krakow, S.L. and Lazar, M.A. (1998) The nuclear eicosanoid receptor, PPARγ is abberantly expressed in colonic tumors. Carcinogenesis, 19, 49-53.
26. Altiok, S., Xu, M. and Spiegelman, B.M. (1997) PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev., 11, 1987-1998.
27. Elstner, E., Mueller, C., Koshizuka, K., Williamson, E.A., Park, D., Asou, H., Shintaku, P., Said, J.W., Heber, D. and Koeffler, H.P. (1998) Ligands for peroxisome proliferator-activated receptor and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl Acad. Sci. USA, 95, 8806-8811.
28. Brunner, N., Thompson, E.W., Spang-Thomsen, M., Rygaard, J., Dano, K. and Zwiebel, J.A. (1992) LacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis. Eur. J. Cancer, 28A, 1989-1995.
29. Pulkkinen, J.O., Elomaa, L., Joensuu, H., Martikainen, P., Servomaa, K. and Grenman, P. (1996) Paclitaxel-induced apoptotic changes followed by time-lapse video microscopy in cell lines established from head and neck cancer. J. Cancer. Res. Oncol., 122, 214-218.
30. Collins, J.A., Schandl, C.A., Young, K.K., Vesely, J. and Willingham, M.C. (1997) Major DNA fragmentation is a late event in apoptosis. J. Histochem. Cytochem., 45, 923-934.
31. Guo, M., Chen, C., Vidair, C., Marino, S., Dewey, W.C. and Ling, C.C. (1997) Characterization of radiation-induced apoptosis in rodent cell lines. Radiat. Res., 147, 295-303.
32. Wyllie, A.H., Beattie, G.J. and Hargreaves, A.D. (1981) Chromatin changes in apoptosis. Histochem. J., 13, 681-692.
33. Walker, N.I., Harmon, B.V., Gobe, G.C. and Kerr, J.F. (1988) Patterns of cell death. Methods. Achiev. Exp. Pathol., 13, 18-54.
34. Compton, M.M. (1992) A biochemical hallmark of apoptosis: internucleosomal degredation of the genome. Cancer Metastasis Rev., 11, 105-119.
35. Brunner, N., Boysen, B., Romer, J. and Spang-Thomsen, M. (1993) The nude mouse model as an in vivo model for human breast cancer invasion and metastasis. Breast Cancer Res. Treat., 24, 257-264.
36. Fowler, S.D. and Greenspan, P. (1985) Application of Nile red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue sections: comparison with oil red O. J. Histochem. Cytochem., 33, 833-836.
37. Greenspan, P., Mayer, E.P. and Fowler, S.D. (1985) Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol., 100, 965-973.
38. Kute, T.E., Shao, Z.M., Sugg, N.K., Long, R.T., Russel, G.B. and Case, L.D. (1992) Cathepsin D and other markers as prognostic indicators for node negative breast cancer patients. Cancer Res., 52, 5198-5203.
39. Sarraf, P., Mueller, E., Jones, D. et al. (1998) Diferentiation and reversal of malignant changes in colon cancer through PPARgamma. Nature Med., 4, 1046-1052.
40. Lefebvre, A.M., Chen, I., Desreumaux, P., Najib, J., Fruchart, J.C., Geboes, K., Briggs, M., Heyman, R. and Auwerx, J. (1998) Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APC/+ mice. Nature Med., 4, 1053-1057.
41. Saez, E., Tontonoz, P., Nelson, M.C., Alvarez, J.G., Ming, U.T., Barid, S.M., Thomazy, V.A and Evans, R.M. (1998) Activators of the nuclear receptor PPARgamma enhance polyp formation. Nature Med., 4, 1058-1061.
42. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J and Glass, C.K. (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature, 39, 79-82.
43. Jiang, C., Ting, A.T. and Seed, B. (1998) PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature, 39, 82-86.
44. Chinetti, G., Griglio, S., Antonucci, M., Torra, I.P., Delerive, P., Majd, Z., Fruchart, J.C., Chapman, J., Najib, J. and Staels, B. (1998) Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem., 273, 25573-25580.
45. Okamura, N. and Terayama, H. (1977) Prostaglandin receptor-adenylate cyclase system in plasma membranes of rat liver and ascites hepatomas. and the effect of GTP upon it. Biochim. Biophys. Acta, 465, 54-67.